1194 related articles for article (PubMed ID: 22353619)
1. PLGA-based nanoparticles: an overview of biomedical applications.
Danhier F; Ansorena E; Silva JM; Coco R; Le Breton A; Préat V
J Control Release; 2012 Jul; 161(2):505-22. PubMed ID: 22353619
[TBL] [Abstract][Full Text] [Related]
2. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
Acharya S; Sahoo SK
Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219
[TBL] [Abstract][Full Text] [Related]
3. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
[TBL] [Abstract][Full Text] [Related]
4. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution of antisense nanoparticles in mammary carcinoma rat model.
Elazar V; Adwan H; Rohekar K; Zepp M; Lifshitz-Shovali R; Berger MR; Golomb G
Drug Deliv; 2010 Aug; 17(6):408-18. PubMed ID: 20429847
[TBL] [Abstract][Full Text] [Related]
6. The effect of autophagy inhibitors on drug delivery using biodegradable polymer nanoparticles in cancer treatment.
Zhang X; Dong Y; Zeng X; Liang X; Li X; Tao W; Chen H; Jiang Y; Mei L; Feng SS
Biomaterials; 2014 Feb; 35(6):1932-43. PubMed ID: 24315578
[TBL] [Abstract][Full Text] [Related]
7. Recent applications of PLGA based nanostructures in drug delivery.
Mir M; Ahmed N; Rehman AU
Colloids Surf B Biointerfaces; 2017 Nov; 159():217-231. PubMed ID: 28797972
[TBL] [Abstract][Full Text] [Related]
8. PLGA-loaded nanomedicines in melanoma treatment: Future prospect for efficient drug delivery.
Das S; Khuda-Bukhsh AR
Indian J Med Res; 2016 Aug; 144(2):181-193. PubMed ID: 27934796
[TBL] [Abstract][Full Text] [Related]
9. Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives.
Pandita D; Kumar S; Lather V
Drug Discov Today; 2015 Jan; 20(1):95-104. PubMed ID: 25277320
[TBL] [Abstract][Full Text] [Related]
10. Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin.
Lee H; Ahn CH; Park TG
Macromol Biosci; 2009 Apr; 9(4):336-42. PubMed ID: 19006195
[TBL] [Abstract][Full Text] [Related]
11. Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems.
Singh J; Pandit S; Bramwell VW; Alpar HO
Methods; 2006 Feb; 38(2):96-105. PubMed ID: 16442811
[TBL] [Abstract][Full Text] [Related]
12. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
[TBL] [Abstract][Full Text] [Related]
13. PLGA/polymeric liposome for targeted drug and gene co-delivery.
Wang H; Zhao P; Su W; Wang S; Liao Z; Niu R; Chang J
Biomaterials; 2010 Nov; 31(33):8741-8. PubMed ID: 20727587
[TBL] [Abstract][Full Text] [Related]
14. Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis.
Amaral AC; Bocca AL; Ribeiro AM; Nunes J; Peixoto DL; Simioni AR; Primo FL; Lacava ZG; Bentes R; Titze-de-Almeida R; Tedesco AC; Morais PC; Felipe MS
J Antimicrob Chemother; 2009 Mar; 63(3):526-33. PubMed ID: 19151037
[TBL] [Abstract][Full Text] [Related]
15. In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.
Chen YS; Alany RG; Young SA; Green CR; Rupenthal ID
Drug Deliv; 2011; 18(7):493-501. PubMed ID: 21696294
[TBL] [Abstract][Full Text] [Related]
16. Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells.
Elamanchili P; Diwan M; Cao M; Samuel J
Vaccine; 2004 Jun; 22(19):2406-12. PubMed ID: 15193402
[TBL] [Abstract][Full Text] [Related]
17. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
[TBL] [Abstract][Full Text] [Related]
18. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity.
Hamdy S; Molavi O; Ma Z; Haddadi A; Alshamsan A; Gobti Z; Elhasi S; Samuel J; Lavasanifar A
Vaccine; 2008 Sep; 26(39):5046-57. PubMed ID: 18680779
[TBL] [Abstract][Full Text] [Related]
20. PLGA: a unique polymer for drug delivery.
Kapoor DN; Bhatia A; Kaur R; Sharma R; Kaur G; Dhawan S
Ther Deliv; 2015 Jan; 6(1):41-58. PubMed ID: 25565440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
